FDA Approves New Drug to Treat Niemann-Pick Disease, Type C | FDA
Sorry for this seemingly out of place article! Just so happens that my grandniece has Niemann-Pick. She is 9 years old and probably will not live much longer. This is a step in the right direction though! FDA approved Aqneursa (levacetylleucine) for the treatment of neurological symptoms associated with Niemann-Pick disease type C (NPC) in adults and pediatric patients weighing at least 15 kg…
Read the full article at: www.fda.gov
Who We Are
Omnica Corporation is a privately-held design, engineering, and medical product development firm located in Irvine, California. The 28-person company is staffed with full-time employees and has been in operation since 1984. Our speciality is custom product development for the medical industry and industrial fields.
Our expertise is developing complex medical devices.Technical personnel at Omnica includes designers, mechanical engineers, electronic and software engineers, advanced R&D specialists, regulatory staff (for FDA documentation), machinists and model makers.
